This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Journal and News Scan
This illustrated, instructional article details a reproducible, total-arterial surgical revascularization technique which does not require cardiopulmonary bypass or any manipulation of the ascending aorta. This guide aims to improve outcomes for surgeons new to off-pump coronary artery bypass grafting (OPCABG) and goes some way to addressing concerns raised by critics of OPCABG.
Exciting debate on the EOLIA trial!
In this Men's Journal feature, Dr. William Novick describes his beginnings in international congenital heart surgery and how the personal credo: "Screw politics, screw religion; I'm here to help" has landed him inside the operating rooms of some of the world's most hostile regions. His experiences in Iraq are guaranteed to make everyday stressors of surgery amidst suboptimal turnover time or administrative oversight seem trivial in comparison to surgery amidst mounting insurgency or ISIS.
In this review article, the authors focus on epigenetic regulation of gene expression, including the role of histone methylation and acetylation, deoxyribonucleic acid methylation, and noncoding ribonucleic acids in the pathogenesis of thoracic aortic aneurysms (TAA) and ascending aortic dissection (AAD). They provide a translational perspective, presenting recent data that motivate the evaluation of the potential of epigenetics to diagnose TAA and prevent ascending aortic dissection AAD.
The Editorial Group is grateful to Dr Manos Kapetanakis for bringing to our attention their small case series on a ' lifestyle' late complication of pneumonectomy for malignancy. It will be challenging to guide the swimmer with curable central pulmonary cancer in making an informed decision on the strength of the sporadic Keeling Syndrome. The biomechanic discussion holds translational value.
Patient Care and General Interest
The heart rate tracker in a man’s smartwatch reportedly warned him of a major heart attack, which may have saved his life.
A surgical team in Nepal performed a rare open heart surgery on a pregnant patient with type A aortic dissection.
Drugs and Devices
A new study suggests that the HDAC inhibitor, which is currently in clinical trials for the treatment of patients with other cancers, may also be useful in treating small-cell lung cancer.
Lung cancer patients have gained access to a potentially life-extending drug in Ireland, following its approval by Ireland’s Health Services.
Research, Trials, and Funding
A recent study published in the British Medical Journal suggests that diclofenac, a commonly used painkiller, is associated with an increased risk of serious cardiovascular problems.
Research from The Francis Crick Institute indicates that a model developed via artificial intelligence is superior at predicting risk of death in patients with heart disease than models designed by medical experts.
Radakovic and colleagues evaluated the effectiveness of the model for end-stage liver disease (MELD) score in predicting long-term survival after pericardiectomy for constrictive pericarditis, using outcomes for 79 patients from their center. The MELD score, an established measure of liver function, was an independent predictor of 1-year mortality after pericardiectomy, and overall survival decreased as the MELD score increased. The authors conclude that assessment of liver dysfunction using the MELD score provides an additional tool to evaluate the risk of pericardiectomy for constrictive pericarditis.
Brigid Ann Scanlan Eiynck, of Scanlan International, has passed away. This article highlights her life and accomplishments.
This Thursday night, September 6, 2018, the world's biggest thoracic surgery unit is broadcasting a free live conference in English. Anyone is free to log in to see what they are doing. They will be presenting and discussing 14 different clinical cases, including lobectomy, segmentectomy, and oesophagectomy.
Click on the link to get a front seat at this conference for free!
The conference is Thursday, September 6, 2018 from 8:00 pm to 6:00 am EST (Friday, September 7, 2018 from 8:00 am to 6:00 pm GMT + 8).
Modolo and colleagues provide detailed analysis and straightforward description of the SYNTAX II and SYNTAX III trials, including the impact for surgeons in contemporary practice. The article addresses both sides of the percutaneous coronary intervention (PCI) versus CABG debate with evidence from the SYNTAX II and III trials, examining specifically the outcomes of state-of-the-art PCI and CABG and comparison of heart team findings and decision making using computed tomographic angiography (including FFRCT) or conventional angiography.